Healthcare provider profile · identity verified

Holly Ellen Mault, ANP, FNP

Nurse Practitioner · HOPEWELL JUNCTION, NY · NPI 1659469310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	435	125
Atorvastatin Calcium	Atorvastatin Calcium	415	103
Amlodipine Besylate	Amlodipine Besylate	354	97
Levothyroxine Sodium	Levothyroxine Sodium	298	77
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	296	31
Losartan Potassium	Losartan Potassium	295	68
Gabapentin	Gabapentin	287	72
Omeprazole	Omeprazole	243	71
Tramadol Hcl	Tramadol Hcl	224	26
Metformin Hcl	Metformin Hcl	205	51
Furosemide	Furosemide	197	53
Metoprolol Succinate	Metoprolol Succinate	192	54
Metoprolol Tartrate	Metoprolol Tartrate	192	50
Hydrochlorothiazide	Hydrochlorothiazide	179	54
Rosuvastatin Calcium	Rosuvastatin Calcium	167	50
Albuterol Sulfate Hfa	Albuterol Sulfate	165	57
Lorazepam	Lorazepam	138	26
Oxycodone Hcl	Oxycodone Hcl	138	19
Pantoprazole Sodium	Pantoprazole Sodium	135	37
Tamsulosin Hcl	Tamsulosin Hcl	135	38
Famotidine	Famotidine	127	38
Trazodone Hcl	Trazodone Hcl	126	33
Hydroxyzine Hcl	Hydroxyzine Hcl	118	27
Sertraline Hcl	Sertraline Hcl	114	26
Potassium Chloride	Potassium Chloride	113	33
Baclofen	Baclofen	109	24
Alprazolam	Alprazolam	108	12
Buspirone Hcl	Buspirone Hcl	106	24
Alendronate Sodium	Alendronate Sodium	105	18
Glipizide	Glipizide	100	25
Clopidogrel	Clopidogrel Bisulfate	97	28
Duloxetine Hcl	Duloxetine Hcl	92	17
Eliquis	Apixaban	91	24
Simvastatin	Simvastatin	88	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	16
Clonidine Hcl	Clonidine Hcl	82	20
Prednisone	Prednisone	76	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	20
Atenolol	Atenolol	71	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	suppressed
Citalopram Hbr	Citalopram Hydrobromide	69	21
Clonazepam	Clonazepam	68	15
Montelukast Sodium	Montelukast Sodium	68	21
Carvedilol	Carvedilol	67	20
Spironolactone	Spironolactone	62	13
Mirtazapine	Mirtazapine	61	17
Diazepam	Diazepam	58	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	57	16
Meloxicam	Meloxicam	56	14
Pregabalin	Pregabalin	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	11
Ventolin Hfa	Albuterol Sulfate	52	16
Escitalopram Oxalate	Escitalopram Oxalate	50	15
Morphine Sulfate Er	Morphine Sulfate	49	suppressed
Cephalexin	Cephalexin	48	26
Ezetimibe	Ezetimibe	48	15
Pravastatin Sodium	Pravastatin Sodium	45	17
Tizanidine Hcl	Tizanidine Hcl	45	12
Jantoven	Warfarin Sodium	44	suppressed
Nitroglycerin	Nitroglycerin	44	22
Ropinirole Hcl	Ropinirole Hcl	44	12
Jardiance	Empagliflozin	41	suppressed
Allopurinol	Allopurinol	40	12
Amitriptyline Hcl	Amitriptyline Hcl	40	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Prazosin Hcl	Prazosin Hcl	37	suppressed
Lovastatin	Lovastatin	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Carisoprodol	Carisoprodol	31	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Ozempic	Semaglutide	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Azithromycin	Azithromycin	27	12
Mupirocin	Mupirocin	27	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	11
Nystatin	Nystatin	26	19
Lithium Carbonate Er	Lithium Carbonate	25	suppressed
Epinephrine	Epinephrine	24	14
Propranolol Hcl	Propranolol Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	14
Bupropion Xl	Bupropion Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	17
Lacosamide	Lacosamide	20	suppressed
Fluconazole	Fluconazole	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Admelog	Insulin Lispro	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Imiquimod	Imiquimod	18	16
Januvia	Sitagliptin Phosphate	18	suppressed
Colchicine	Colchicine	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Finasteride	Finasteride	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Humira(Cf) Pen	Adalimumab	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Minocycline Hcl	Minocycline Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Budesonide Dr	Budesonide	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error